全文获取类型
收费全文 | 2317篇 |
免费 | 189篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 55篇 |
儿科学 | 112篇 |
妇产科学 | 97篇 |
基础医学 | 283篇 |
口腔科学 | 49篇 |
临床医学 | 293篇 |
内科学 | 339篇 |
皮肤病学 | 19篇 |
神经病学 | 182篇 |
特种医学 | 220篇 |
外科学 | 285篇 |
综合类 | 97篇 |
一般理论 | 1篇 |
预防医学 | 176篇 |
眼科学 | 25篇 |
药学 | 173篇 |
中国医学 | 3篇 |
肿瘤学 | 112篇 |
出版年
2021年 | 17篇 |
2020年 | 22篇 |
2019年 | 19篇 |
2018年 | 14篇 |
2017年 | 31篇 |
2016年 | 26篇 |
2015年 | 32篇 |
2014年 | 48篇 |
2013年 | 71篇 |
2012年 | 64篇 |
2011年 | 62篇 |
2010年 | 57篇 |
2009年 | 62篇 |
2008年 | 61篇 |
2007年 | 91篇 |
2006年 | 70篇 |
2005年 | 69篇 |
2004年 | 81篇 |
2003年 | 82篇 |
2002年 | 83篇 |
2001年 | 80篇 |
2000年 | 88篇 |
1999年 | 75篇 |
1998年 | 63篇 |
1997年 | 64篇 |
1996年 | 57篇 |
1995年 | 51篇 |
1994年 | 37篇 |
1993年 | 40篇 |
1992年 | 48篇 |
1991年 | 71篇 |
1990年 | 68篇 |
1989年 | 63篇 |
1988年 | 70篇 |
1987年 | 64篇 |
1986年 | 47篇 |
1985年 | 54篇 |
1984年 | 37篇 |
1983年 | 21篇 |
1982年 | 28篇 |
1981年 | 27篇 |
1980年 | 26篇 |
1979年 | 31篇 |
1978年 | 33篇 |
1977年 | 38篇 |
1976年 | 28篇 |
1975年 | 20篇 |
1974年 | 15篇 |
1972年 | 13篇 |
1967年 | 10篇 |
排序方式: 共有2521条查询结果,搜索用时 0 毫秒
101.
102.
Smith AJ Robertson D Tang MK Jackson MS MacKenzie D Bagg J 《British dental journal》2003,195(12):701-3; discussion 694
OBJECTIVE: A retrospective analysis of laboratory data to investigate the isolation of Staphylococcus aureus from the oral cavity and facial area in specimens submitted to a regional diagnostic oral microbiology laboratory. METHODS: A hand search of laboratory records for a three-year period (1998-2000) was performed for specimens submitted to the regional diagnostic oral microbiology laboratory based at Glasgow Dental Hospital and School. Data were collected from forms where S. aureus was isolated. These data included demographics, referral source, specimen type, methicillin susceptibility and clinical details. RESULTS: For the period 1998-2000, there were 5,005 specimens submitted to the laboratory. S. aureus was isolated from 1,017 specimens, of which 967 (95%) were sensitive to methicillin (MSSA) and 50 (5%) were resistant to methicillin (MRSA). The 1,017 specimens were provided from 615 patients. MRSA was isolated from 37 (6%) of patients. There was an increasing incidence of S. aureus with age, particularly in the >70 years age group. The most common specimen from which MSSA was isolated was an oral rinse (38%) whilst for MRSA isolates this was a tongue swab (28%). The clinical condition most commonly reported for MSSA isolates was angular cheilitis (22%). Erythema, swelling, pain or burning of the oral mucosa was the clinical condition most commonly reported for MRSA isolates (16%). Patients from whom the MSSA isolates were recovered were most commonly (55%) seen in the oral medicine clinic at the dental hospital, whilst patients with MRSA were more commonly seen in primary care settings such as nursing homes, hospices and general dental practice (51%). CONCLUSION: In line with more recent surveys, this retrospective study suggests that S. aureus may be a more frequent isolate from the oral cavity than hitherto suspected. A small proportion of the S. aureus isolates were MRSA. There were insufficient data available to determine whether the S. aureus isolates were colonising or infecting the oral cavity. However, the role of S. aureus in several diseases of the oral mucosa merits further investigation. 相似文献
103.
Factors influencing the decision to amputate or reconstruct after high-energy lower extremity trauma
MacKenzie EJ Bosse MJ Kellam JF Burgess AR Webb LX Swiontkowski MF Sanders R Jones AL McAndrew MP Patterson B McCarthy ML Rohde CA;LEAP Study Group 《The Journal of trauma》2002,52(4):641-649
BACKGROUND: Factors thought to influence the decision for limb salvage include injury severity, physiologic reserve of the patient, and characteristics of the patient and their support system. METHODS: Eligible patients were between the ages of 16 and 69 with Gustilo type IIIB and IIIC tibial fractures, dysvascular limbs resulting from trauma, type IIIB ankle fractures, or severe open midfoot or hindfoot injuries. Data collected at enrollment relevant to the decision-making process included injury characteristics and its treatment, and the nature and severity of other injuries. Logistic regression and stepwise modeling were used to determine the effect of each covariate on the variable salvage/ amputation. RESULTS: Of 527 patients included in the analysis, 408 left the hospital with a salvaged limb. Of the 119 amputations performed, 55 were immediate and 64 were delayed. The multivariate analysis confirmed the bivariate analysis: all injury characteristics remained significant predictors of limb status with the exception of bone loss; and soft tissue injury and absence of plantar sensation were the most important factors in accounting for model validity. CONCLUSION: Soft tissue injury severity has the greatest impact on decision making regarding limb salvage versus amputation. 相似文献
104.
Docagne F Nicole O Gabriel C Fernández-Monreal M Lesné S Ali C Plawinski L Carmeliet P MacKenzie ET Buisson A Vivien D 《Molecular and cellular neurosciences》2002,21(4):634-644
The intravenous injection of the serine protease, tissue-type plasminogen activator (t-PA), has shown to benefit stroke patients by promoting early reperfusion. However, it has recently been suggested that t-PA activity, in the cerebral parenchyma, may also potentiate excitotoxic neuronal death. The present study has dealt with the role of the t-PA inhibitor, PAI-1, in the neuroprotective activity of the cytokine TGF-beta1 and focused on the transduction pathway involved in this effect. We demonstrated that PAI-1, produced by astrocytes, mediates the neuroprotective activity of TGF-beta 1 against N-methyl-D-aspartate (NMDA) receptor-mediated excitotoxicity. This t-PA inhibitor, PAI-1, protected neurons against NMDA-induced neuronal death by modulating the NMDA-evoked calcium influx. Finally, we showed that the activation of the Smad3-dependent transduction pathway mediates the TGF-beta-induced up-regulation of PAI-1 and subsequent neuroprotection. Overall, this study underlines the critical role of the t-PA/PAI-1 axis in the regulation of glutamatergic neurotransmission. 相似文献
105.
In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine) 总被引:4,自引:0,他引:4
McClue SJ Blake D Clarke R Cowan A Cummings L Fischer PM MacKenzie M Melville J Stewart K Wang S Zhelev N Zheleva D Lane DP 《International journal of cancer. Journal international du cancer》2002,102(5):463-468
CDK2 inhibitors have been proposed as effective anti-cancer therapeutics. We show here that CYC202 (R-roscovitine) is a potent inhibitor of recombinant CDK2/cyclin E kinase activity (IC(50) = 0.10 microM) with an average cytotoxic IC(50) of 15.2 microM in a panel of 19 human tumour cell lines, and we also demonstrate selectivity for rapidly proliferating cells over non-proliferating cells. A study of the cell cycle effects of CYC202 in Lovo colorectal carcinoma cells showed that the major effect was not the predicted arrest in one part of the cycle, but rather an induction of cell death from all compartments of the cell cycle. The maximum tolerated dose given intravenously to mice was in excess of 20 mg/kg. Doses up to 2,000 mg/kg were tolerated when administered orally in mice. Following repeated intraperitoneal administration (3 times daily for 5 days) of 100 mg/kg to nude mice bearing the Lovo human colorectal tumour, CYC202 induced a significant antitumour effect with a 45% reduction in tumour growth compared to controls. A second experiment using the human uterine xenograft MESSA-DX5 treated with orally administered CYC202 (500 mg/kg 3 times daily for 4 days) also exhibited a significant reduction in the rate of growth of the tumour (62%). These data, showing enzyme and cellular potency together with antitumour activity, confirm the potential of CDK2 inhibitors such as CYC202 as anticancer drugs. 相似文献
106.
107.
New Zealand community attitudes toward people with epilepsy 总被引:3,自引:3,他引:0
PURPOSE: International surveys on knowledge and attitudes toward people with epilepsy suggest that public opinion is improving in many countries. This study aimed to discover how New Zealand compared with other countries, and how subgroups within the New Zealand population compared with each other, by conducting a survey of community knowledge and attitudes toward epilepsy. METHODS: Telephone interviews were conducted on a random sample of 400 persons older than 17 years, drawn from a mid-sized provincial town and its hinterland. RESULTS: Ninety-five percent of respondents had heard or read about epilepsy; 73% knew someone with epilepsy; and 67% had seen an epileptic seizure. Somewhat less knowledgeable were young people, the less educated, lower socioeconomic status (SES), and those of Maori or non-European ethnicity. Attitudes toward people with epilepsy were favorable, with only 5% objecting to their child marrying a person who sometimes had seizures. Less-positive attitudes were found among some older people. CONCLUSIONS: Compared with those in other Western countries, New Zealanders are well informed about epilepsy, and their attitudes toward it are mainly positive. Continuing public education about epilepsy is still necessary, especially among the young, the non-European, and older people. 相似文献
108.
Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases 总被引:1,自引:0,他引:1
J M F G Aerts C E M Hollak M van Breemen M Maas J E M Groener RG Boot 《Acta paediatrica (Oslo, Norway : 1992)》2005,94(S447):43-46
The value of biomarkers in the clinical management of lysosomal storage diseases is best illustrated by the present use of plasma chitotriosidase levels in the diagnosis and monitoring of Gaucher disease. The enzyme chitotriosidase is specifically produced and secreted by the pathological storage macrophages (Gaucher cells). Plasma chitotriosidase levels are elevated on average 1000-fold in symptomatic patients with Gaucher disease and reflect the body burden on storage cells. Changes in plasma chitotriosidase reflect changes in clinical symptoms. Monitoring of plasma chitotriosidase levels is nowadays commonly used in decision making regarding initiation and optimization of costly therapeutic interventions (enzyme replacement therapy or substrate reduction therapy). A novel substrate has been developed that further facilitates the measurement of chitotriosidase in plasma samples. Moreover, an alternative Gaucher-cell marker, CCL18, has been very recently identified and can also be employed to monitor the disease, particularly in those patients lacking chitotriosidase due to a genetic mutation. There is a need for comparable surrogate markers for other lysosomal storage diseases and the search for such molecules is an area of intense investigation.
Conclusion: The use of biomarkers can provide valuable insight into the molecular pathogenesis of LSDs, such as Gaucher disease and Fabry disease. 相似文献
Conclusion: The use of biomarkers can provide valuable insight into the molecular pathogenesis of LSDs, such as Gaucher disease and Fabry disease. 相似文献
109.
110.
S El-Sayed A Nabid W Shelley J Hay J Balogh M Gelinas R MacKenzie N Read E Berthelet H Lau J Epstein P Delvecchio P K Ganguly F Wong P Burns D Tu J Pater 《Journal of clinical oncology》2002,20(19):3956-3963
PURPOSE: Mucositis occurs in almost all patients treated with radiotherapy for head and neck cancer. The aim of this multicenter, double-blind, prospective, randomized trial was to evaluate the clinical efficacy of an economically viable antimicrobial lozenge (bacitracin, clotrimazole, and gentamicin [BcoG]) in the alleviation of radiation-induced mucositis in patients with head and neck cancer. PATIENTS AND METHODS: One hundred thirty-seven eligible patients were randomized to treatment with either antimicrobial lozenge (69 patients) or placebo lozenge (68 patients). The primary end point of the study was the time to development of severe mucositis from the start of radiotherapy. Secondary end points included severity and duration of mucositis, pain measurement, radiation therapy interruption, and quality of life. Mucositis was scored using a validated mucositis scoring system. RESULTS: Toxicity profiles were similar between the two arms of the study. The median time to development of severe mucositis from the start of radiotherapy was 3.61 weeks on BCoG and 3.96 weeks on placebo (P =.61). There were no statistically significant differences between the arms in the extent of severe mucositis as measured by physician, in oral toxicities as recorded by patients, or in radiotherapy delays. CONCLUSION: This study was conducted on the basis of a pilot study that demonstrated the BCoG lozenge to be tolerable and microbiologically efficacious. A validated mucositis scoring system was used. However, in this group of patients treated with conventional radiotherapy, the lozenge did not impact significantly on the severity of mucositis. Whether such a lozenge would be beneficial in treatment situations where rate of severe mucositis is higher (ie, in patients treated with unconventional fractionation or with concomitant chemotherapy) is unknown. 相似文献